Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Other Working Capital Changes of -$1.4 million in Q1 2026, down 642.8% quarter-over-quarter from $264000.0 in Q4 2025, and up 36.06% on a YoY basis from -$1.1 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 36.06% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at $627000.0 (up 137.68% YoY), while the FY2025 annual figure was -$181000.0, down 18.3% from the prior year.
- Other Working Capital Changes was -$1.4 million for Q1 2026 at Maravai Lifesciences Holdings, down from $264000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $14.2 million in Q3 2025 to a low of -$12.4 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged -$950882.4 across 5 years, with a median of -$2.2 million in 2025.
- Biggest YoY gain for Other Working Capital Changes was 645.42% in 2023; the steepest drop was 321.26% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$8.9 million in 2022, then jumped by 37.86% to -$5.5 million in 2023, then jumped by 114.82% to $817000.0 in 2024, then plunged by 67.69% to $264000.0 in 2025, then slumped by 642.8% to -$1.4 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.4 million (Q1 2026), $264000.0 (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.43 Mn |
| Mar 31, 2026 | -1.43 Mn |
| Dec 31, 2025 | 264,000.00 |
| Dec 31, 2025 | 264,000.00 |
| Sep 30, 2025 | 14.23 Mn |
| Sep 30, 2025 | 14.23 Mn |
| Jun 30, 2025 | -12.44 Mn |
| Jun 30, 2025 | -12.44 Mn |
| Mar 31, 2025 | -2.24 Mn |
| Mar 31, 2025 | -2.24 Mn |
| Dec 31, 2024 | 817,000.00 |
| Dec 31, 2024 | 817,000.00 |
| Sep 30, 2024 | 3.88 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | -4.12 Mn |
| Jun 30, 2024 | -4.12 Mn |
| Mar 31, 2024 | -730,000.00 |
| Mar 31, 2024 | -730,000.00 |
| Dec 31, 2023 | -5.51 Mn |
| Dec 31, 2023 | -5.51 Mn |